Results 181 to 190 of about 692,603 (317)
This study analyzed data from consecutive patients with stage III colorectal cancer following curative resection and examined the reason for not introducing adjuvant chemotherapy (AC) and the differences in prognosis between completed and incomplete AC in elderly and non‐elderly patients.
Takuya Shiraishi+8 more
wiley +1 more source
Network Mendelian randomisation analysis deciphers protein pathways linking type 2 diabetes and gastrointestinal disease. [PDF]
Geng J+12 more
europepmc +1 more source
A Case of Immunoglobulin G4-Related Gastrointestinal Disease Diagnosed From Persistent Diarrhea and Abdominal Pain. [PDF]
Hirano T+10 more
europepmc +1 more source
The Use of Prosthetic Stents in Tracheobronchial,Gastrointestinal, and Genitourinary Diseases [PDF]
Eric S. Edell+3 more
openalex +1 more source
PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer
Pancreatic ductal adenocarcinoma features abundant stromal components that hinder therapy efficacy. Single‐cell RNA sequencing analysis combined with experiments identified PPY, a gastrointestinal hormone, as a novel inducer of immunosuppressive iCAFs. Mechanistic studies revealed that PPY activates the non‐canonical NF‐κB pathway via EGFR.
Mengdie Cao+14 more
wiley +1 more source
High tumor budding is a new candidate for an additional determinant of the T category in staging ICC. An LCSGJ staging system containing an additional evaluation of tumor budding may lead to improved staging accuracy. Abstract Purpose This retrospective study evaluated our hypothesis that high tumor budding (≥10 buds) may help determine the appropriate
Hisashi Kosaka+9 more
wiley +1 more source
Management Effects on Gastrointestinal Disease in Red Wolves (Canis rufus) Under Human Care: A Retrospective Study. [PDF]
Fontaine AC+7 more
europepmc +1 more source
COVID-19 and Gastrointestinal Disease: Current Insights and Future Management. [PDF]
Kopel J, Goyal H.
europepmc +1 more source
DELAYED ONSET OF GASTROINTESTINAL DISEASE IN THE RECIPIENTS OF BONE MARROW TRANSPLANTS
Fredric T. Serota+4 more
openalex +1 more source